Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.

Camille GauvinVimal KrishnanImane KaciDanh Tran-ThanhKarine BédardRoula AlbadineCharles LeducLouis Arthur Gaboury Normand BlaisMustapha TehfeBertrand RoutyMarie Florescu

Published in: Current oncology (Toronto, Ont.) (2021)

Aggressive treatments of oligometastatic NSCLC significantly improve mOS and mPFS compared to a more palliative approach. PD-L1 expression is a negative prognostic factor which suggests a possible role for immunotherapy in this setting.

Keyphrases

prognostic factors
small cell lung cancer
advanced non small cell lung cancer
combination therapy
highly efficient
gold nanoparticles